NIH's abrupt policy change caps indirect research costs at 15%, sparking debate over its impact on scientific progress and ...
The National Institutes of Health (NIH) on Friday made a significant reduction in grants reserved for research institutions, a decision that may significantly impact American higher education.
“Without relief from NIH’s action, these institutions’ cutting-edge work to cure and treat human disease will grind to a halt.” The NIH is the primary source of federal funding for medical ...
The money supports “the research infrastructure,” said Iwashyna, who relies on NIH funding for research on chronic illnesses, including pneumonia, among the leading causes of hospitalizations ...
Tabak, a dentist and researcher, was appointed as the NIH’s principal deputy director in 2010. His tenure spans four presidential administrations, and includes a nearly two-year stint as the ...
The U.S. National Institutes of Health (NIH) is the largest funder of biomedical research in the world, and its grants create the foundation of basic science knowledge on which major health ...
The NIH is led by one agency director and five deputies. With Lauer’s departure, two of those deputies have left in as many days, and the agency is currently being led by an acting director ...
Research leaders contend that the NIH decision will damage America’s ability to compete with China and other nations on the frontier of biomedicine. Although it is framed as a simple cost ...
The NIH, the largest funder of biomedical research in the U.S., will limit funding for indirect costs to 15%. Indirect costs cover expenses like building maintenance and administrative salaries.
A clinical trial supported by the National Institutes of Health (NIH) is testing an experimental treatment designed to help people suffering the effects of dengue, a mosquito-borne viral disease.
She added that the NIH cuts “would be devastating, stopping vital biomedical research,” even as the White House claimed that their policy wouldn’t affect biomedical research at all.
Those costs were previously individually negotiated; the NIH said the average rate was around 28%, with some over 60%. Calling the cuts "arbitrary and capricious," 22 states sued the Trump ...